Get the Stockscreener App
5.39
0.58%
0.02
Mannkind Corp stock is traded at $5.39, with a volume of 1.54M.
It is up +0.58% in the last 24 hours and up +17.67% over the past month.
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
See More
Previous Close:
$5.37
Open:
$5.39
24h Volume:
1.54M
Relative Volume:
0.39
Market Cap:
$1.65B
Revenue:
$248.37M
Net Income/Loss:
$11.74M
P/E Ratio:
107.80
EPS:
0.05
Net Cash Flow:
$18.24M
1W Performance:
+1.34%
1M Performance:
+17.67%
6M Performance:
+9.12%
1Y Performance:
-13.72%
1-Day Range:
$5.355
$5.55
1-Week Range:
$5.185
$5.62
52-Week Range:
$3.3812
$7.63
Mannkind Corp Stock (MNKD) Company Profile
Name
Mannkind Corp
Sector
Industry
Phone
818-661-5000
Address
1 CASPER STREET, DANBURY, CA
Compare MNKD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
5.38 | 1.65B | 248.37M | 11.74M | 18.24M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.10 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
607.14 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.79 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
776.00 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
345.21 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-16-25 | Resumed | H.C. Wainwright | Buy |
| Apr-10-25 | Initiated | Mizuho | Outperform |
| Feb-10-25 | Initiated | Wedbush | Outperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Dec-19-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-24 | Resumed | Leerink Partners | Outperform |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-10-23 | Initiated | Wedbush | Outperform |
| May-14-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-24-19 | Initiated | Oppenheimer | Outperform |
| Oct-25-19 | Initiated | Cantor Fitzgerald | Overweight |
| May-14-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
| Feb-22-19 | Initiated | SVB Leerink | Outperform |
| Feb-28-18 | Downgrade | Maxim Group | Hold → Sell |
| Nov-01-17 | Downgrade | Maxim Group | Buy → Hold |
| Oct-10-17 | Initiated | H.C. Wainwright | Buy |
| Oct-06-17 | Reiterated | Maxim Group | Buy |
| Aug-11-17 | Initiated | Maxim Group | Buy |
| May-10-16 | Reiterated | Piper Jaffray | Underweight |
| May-10-16 | Reiterated | RBC Capital Mkts | Underperform |
| Jan-06-16 | Reiterated | Piper Jaffray | Underweight |
| Jan-06-16 | Reiterated | RBC Capital Mkts | Underperform |
| Nov-04-15 | Downgrade | RBC Capital Mkts | Outperform → Underperform |
| Sep-09-15 | Downgrade | Piper Jaffray | Neutral → Underweight |
| Aug-03-15 | Reiterated | RBC Capital Mkts | Outperform |
| May-11-15 | Downgrade | JP Morgan | Neutral → Underweight |
| May-11-15 | Reiterated | MLV & Co | Hold |
| Apr-16-15 | Reiterated | RBC Capital Mkts | Outperform |
View All
Mannkind Corp Stock (MNKD) Latest News
Key metrics from MannKind Corporation’s quarterly dataCEO Change & Precise Entry and Exit Recommendations - newser.com
Is MannKind Corporation a good long term investmentSector ETF Performance & Take Advantage of Momentum Stocks - earlytimes.in
MannKind (MNKD) Appoints New Chief Medical Officer - GuruFocus
MNKD Appoints New Chief Medical Officer to Strengthen Leadership Team - GuruFocus
MannKind appoints Ajay Ahuja as chief medical officer - Investing.com
MannKind Corporation Appoints Dr. Ajay Ahuja as Chief Medical Officer - Quiver Quantitative
MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer - Yahoo Finance
Will MannKind Corporation (NNFN) stock see insider accumulationJuly 2025 Rallies & Stock Timing and Entry Methods - newser.com
Is MannKind Corporation (NNFN) stock undervalued historically2025 Technical Overview & Stepwise Swing Trade Plans - newser.com
Why MannKind Corporation (NNFN) stock is trending on social mediaEntry Point & High Accuracy Swing Trade Signals - newser.com
Will a bounce in MannKind Corporation offer an exitEarnings Overview Summary & Community Verified Swing Trade Signals - newser.com
Non Tuberculous Mycobacterial Infections Market Dynamics - openPR.com
MannKind (NASDAQ:MNKD) Shares Down 5%Time to Sell? - MarketBeat
MannKind (NASDAQ:MNKD) Earns Buy Rating from HC Wainwright - MarketBeat
MannKind Corporation (NASDAQ:MNKD) Sees Significant Drop in Short Interest - MarketBeat
Insider Selling: MannKind (NASDAQ:MNKD) Insider Sells 47,000 Shares of Stock - MarketBeat
Goldman Sachs Group Inc. Sells 780,939 Shares of MannKind Corporation $MNKD - MarketBeat
MannKind (NASDAQ:MNKD) Trading Down 4.2%Should You Sell? - MarketBeat
MNKD: HC Wainwright & Co. Reiterates Buy Rating with $11 Target - GuruFocus
MannKind (MNKD) chief people officer sells $250,980 in stock By Investing.com - Investing.com UK
Insider Sell Alert: Stuart Tross Sells 47,000 Shares of MannKind Corp (MNKD) - GuruFocus
MannKind (MNKD) chief people officer sells $250,980 in stock - Investing.com
Hedge Fund Bets: Can MannKind Corporation outperform under higher oil prices2025 Earnings Surprises & AI Powered Market Entry Strategies - خودرو بانک
Hedge Fund Moves: Can MannKind Corporation stock double in the next year2025 Performance Recap & Growth Focused Entry Reports - khodrobank.com
Can MannKind Corporation outperform in the next rallyQuarterly Risk Review & Verified Swing Trading Watchlist - خودرو بانک
Weekly Recap: What is MannKind Corporations P E ratio telling usQuarterly Investment Review & Consistent Return Strategy Ideas - خودرو بانک
Analyst Calls: Can MannKind Corporation navigate macro headwindsGold Moves & Consistent Profit Trading Strategies - خودرو بانک
Jacobs Levy Equity Management Inc. Increases Stock Holdings in MannKind Corporation $MNKD - MarketBeat
Millennium Management LLC Purchases 2,375,198 Shares of MannKind Corporation $MNKD - MarketBeat
Mannkind Corp Stock (MNKD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):